Ube3a unsilencer for the potential treatment of Angelman syndrome

被引:2
作者
Vihma, Hanna [1 ]
Li, Kelin [2 ]
Welton-Arndt, Anna [3 ]
Smith, Audrey L. [1 ]
Bettadapur, Kiran R. [1 ]
Gilmore, Rachel B. [4 ]
Gao, Eric [1 ]
Cotney, Justin L. [4 ]
Huang, Hsueh-Cheng [5 ]
Collins, Jon L. [6 ]
Chamberlain, Stormy J. [4 ]
Lee, Hyeong-Min [1 ,7 ]
Aube, Jeffrey [2 ,3 ]
Philpot, Benjamin D. [1 ]
机构
[1] Univ North Carolina Chapel Hill, Carolina Inst Dev Disabil, Neurosci Ctr, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA
[2] Univ North Carolina Chapel Hill, UNC Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA
[3] Univ North Carolina Chapel Hill, Dept Chem, Chapel Hill, NC 27599 USA
[4] Univ Connecticut, Sch Med, Dept Genet & Genome Sci, Farmington, CT USA
[5] Deerfield Management, Deerfield Discovery & Dev, New York, NY USA
[6] Univ North Carolina Chapel Hill, Off Vice Chancellor Res, Chapel Hill, NC USA
[7] Med Univ South Carolina, Hollings Canc Ctr, Dept Biochem & Mol Biol, Charleston, SC 29425 USA
关键词
UBIQUITIN LIGASE; 3-AMINOPYRAZOLE INHIBITORS; ANTITUMOR AGENTS; GENE; EXPRESSION; CDK2/CYCLIN; MUTATIONS; THERAPY; CELLS;
D O I
10.1038/s41467-024-49788-8
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Deletion of the maternal UBE3A allele causes Angelman syndrome (AS); because paternal UBE3A is epigenetically silenced by a long non-coding antisense (UBE3A-ATS) in neurons, this nearly eliminates UBE3A protein in the brain. Reactivating paternal UBE3A holds promise for treating AS. We previously showed topoisomerase inhibitors can reactivate paternal UBE3A, but their therapeutic challenges prompted our search for small molecule unsilencers with a different mechanism of action. Here, we found that (S)-PHA533533 acts through a novel mechanism to significantly increase paternal Ube3a mRNA and UBE3A protein levels while downregulating Ube3a-ATS in primary neurons derived from AS model mice. Furthermore, peripheral delivery of (S)-PHA533533 in AS model mice induces widespread neuronal UBE3A expression. Finally, we show that (S)-PHA533533 unsilences paternal UBE3A in AS patient-derived neurons, highlighting its translational potential. Our findings provide a lead for developing a small molecule treatment for AS that could be safe, non-invasively delivered, and capable of brain-wide unsilencing of paternal UBE3A.
引用
收藏
页数:16
相关论文
共 50 条
[1]   Functional rescue in an Angelman syndrome model following treatment with lentivector transduced hematopoietic stem cells [J].
Adhikari, Anna ;
Copping, Nycole A. ;
Beegle, Julie ;
Cameron, David L. ;
Deng, Peter ;
O'Geen, Henriette ;
Segal, David J. ;
Fink, Kyle D. ;
Silverman, Jill L. ;
Anderson, Joseph S. .
HUMAN MOLECULAR GENETICS, 2021, 30 (12) :1067-1083
[2]   Adverse Drug Reactions and Toxicity of the Food and Drug Administration-Approved Antisense Oligonucleotide Drugs [J].
Alhamadani, Feryal ;
Zhang, Kristy ;
Parikh, Rajvi ;
Wu, Hangyu ;
Rasmussen, Theodore P. ;
Bahal, Raman ;
Zhong, Xiao-Bo ;
Manautou, Jose E. .
DRUG METABOLISM AND DISPOSITION, 2022, 50 (06) :879-887
[3]   CellProfiler: image analysis software for identifying and quantifying cell phenotypes [J].
Carpenter, Anne E. ;
Jones, Thouis Ray ;
Lamprecht, Michael R. ;
Clarke, Colin ;
Kang, In Han ;
Friman, Ola ;
Guertin, David A. ;
Chang, Joo Han ;
Lindquist, Robert A. ;
Moffat, Jason ;
Golland, Polina ;
Sabatini, David M. .
GENOME BIOLOGY, 2006, 7 (10)
[4]   Box C/D small nucleolar RNA genes and the Prader-Willi syndrome: a complex interplay [J].
Cavaille, Jerome .
WILEY INTERDISCIPLINARY REVIEWS-RNA, 2017, 8 (04)
[5]   Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes [J].
Chamberlain, Stormy J. ;
Chen, Pin-Fang ;
Ng, Khong Y. ;
Bourgois-Rocha, Fany ;
Lemtiri-Chlieh, Fouad ;
Levine, Eric S. ;
Lalande, Marc .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (41) :17668-17673
[6]   Biodistribution of Adeno-Associated Virus Gene Therapy Following Cerebrospinal Fluid-Directed Administration [J].
Chen, Xin ;
Lim, Daniel A. ;
Lawlor, Michael W. ;
Dimmock, David ;
Vite, Charles H. ;
Lester, Thomas ;
Tavakkoli, Fatemeh ;
Sadhu, Chanchal ;
Prasad, Suyash ;
Gray, Steven J. .
HUMAN GENE THERAPY, 2023, 34 (3-4) :94-111
[7]   Prenatal delivery of a therapeutic antisense oligonucleotide achieves broad biodistribution in the brain and ameliorates Angelman syndrome phenotype in mice [J].
Clarke, Maria T. ;
Remesal, Laura ;
Lentz, Lea ;
Tan, Danielle J. ;
Young, David ;
Thapa, Slesha ;
Namuduri, Shalini R. ;
Borges, Beltran ;
Kirn, Georgia ;
Valencia, Jasmine ;
Lopez, Manuel E. ;
Lui, Jan H. ;
Shiow, Lawrence R. ;
Dindot, Scott ;
Villeda, Saul ;
Sanders, Stephan J. ;
Mackenzie, Tippi C. .
MOLECULAR THERAPY, 2024, 32 (04) :935-951
[8]   Angelman syndrome: a review of the clinical and genetic aspects [J].
Clayton-Smith, J ;
Laan, L .
JOURNAL OF MEDICAL GENETICS, 2003, 40 (02) :87-95
[9]   Biochemical analysis of Angelman syndrome-associated mutations in the E3 ubiquitin ligase E6-associated protein [J].
Cooper, EM ;
Hudson, AW ;
Amos, J ;
Wagstaff, J ;
Howley, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (39) :41208-41217
[10]   Adeno-Associated Virus-Mediated Rescue of the Cognitive Defects in a Mouse Model for Angelman Syndrome [J].
Daily, Jennifer L. ;
Nash, Kevin ;
Jinwal, Umesh ;
Golde, Todd ;
Rogers, Justin ;
Peters, Melinda M. ;
Burdine, Rebecca D. ;
Dickey, Chad ;
Banko, Jessica L. ;
Weeber, Edwin J. .
PLOS ONE, 2011, 6 (12)